Spear Bio

Woburn, MA · Founded 2021 · Privately Held (backing)

Developer of ultrasensitive protein detection technology designed to offer significant benefits across the healthcare value chain. Spear Bio is based in Woburn, MA and was founded in 2021. Its last known valuation is $134 million. It has raised $69.8 million across 4 recorded rounds; the latest was a $45 million early-stage round in Jul 2024.

Last price · $/share
—
Implied valuation
$134.0M
Total raised
$69.8M
Last round
Early Stage VC
Jul 2024

Who backs Spear Bio?

9 investors
InvestorType
Hongshan Capital GroupOther
CDH InvestmentsPE / buyout
Yonghua CapitalOther
Foresite CapitalVenture capital
Maverick VenturesHedge fund
Harvard UniversityOther
Bio-Techne—
Wyss Institute at Harvard University—
Yonjin Venture—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Spear Bio investors

9 investors are on record for Spear Bio, including Hongshan Capital Group, CDH Investments, Yonghua Capital and Foresite Capital. The early-stage round in Jul 2024 drew 8 investors.

Free account
More of Spear Bio with a free account
  • ·Watch Spear Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Spear Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View